Clinical trial

RICE: Remission by Intra-articular Injection Plus CErtolizumab

NCT02293590

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-11-01

PhasePHASE2

Study timeline

Study start (actual)2013-11-01Date precision: month

Registry last updated2018-08-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

Certolizumab PegolDRUG · verified · RxNorm: certolizumab pegol

Sponsors & collaborators

Rüdiger B. Müllerlead sponsor

UCB Pharmacollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02293590 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.